VHL and renal cell carcinoma: On the other hand, suppressed cell proliferation (>50% reduction in colony formation assay) with azacytidine therapy was detected, both in cell lines with VHL promoter methylation and also in some RCC cell lines without VHL TSG methylation, thus suggesting that multiple methylated TSGs might determine the response to demethylating therapies [198].